Bioheart, Inc. (BHRT) Signs Regenerative Medicine-Focused Joint Venture with Magnum Cell Therapies
Bioheart, a company focused on the discovery, development, and commercialization of autologous cell therapies for the treatment of degenerative diseases, has entered into a joint venture with Magnum Cell Therapies. Magnum Cell Therapies is engaged in providing cutting-edge regenerative medicine therapies to patients suffering from degenerative diseases. The company’s facilities include a state-of-the-art clinic and laboratory located in Honduras. "We are thrilled to work with the team of specialists and scientists at Magnum. The facilities are top-notch and we are hopeful that Bioheart therapies can help many patients," Bioheart Chief Science Officer Kristin Comella stated in the news release. Per…